Pantothenate kinase associated neurodegeneration (Hallervorden - Spatz Syndrome)

Indian Journal of Pediatrics

Volumn 72, Issue 3, 2005, Pages 261-263

  Kapoor, Seeina ^b,c   Hörtnagel, Konstanze ^a   Gogia, Siddhartha ^b   Paul, Ritu ^b   Malhotra, Vishal ^b   Prakash, Anjali ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c Guru Harkrishan Hospital (DSGMC)   (India)

Author keywords

Hallervorden spatz syndrome; PANK 2 gene; Pantothenate kinase associated neurodegeneration

Indexed keywords

PANTOTHENATE KINASE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHOREOATHETOSIS; DYSTONIA; FEMALE; GENE; GENE MUTATION; HALLERVORDEN SPATZ DISEASE; HUMAN; MENTAL DETERIORATION; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANK 2 GENE; PYRAMIDAL SIGN; RIGIDITY; SCHOOL CHILD;

EID: 17244374222     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02859271     Document Type: Article

References (9)

1. Cossu G, Melis M, Floris G, Hayflick S, Spissu A. Hallervorden Spatz Syndrome (Pantothenate Kinase associated neurodegeneration) in 2 Sardinian brothers with homozygous mutation in the PANK 2 gene. J Neurol 2002; 249: 1599-1600.
2. Zhou B, Westaway SK, Levinson B, Johnson MA, Gischier J, Hayflick SJ. A novel Pantothenate Kinase gene is defective in Hallervorden Spatz syndrome. Nat Gen 2001; 28(4): 345-349.
3. th edn. San Deigo; Arbot Publications, 1998.
4. Peña AJ, Molina O, Cardozo J. Hallervorden Spatz disease: Two new early onset cases. J Child Neurol 2000; 15: 30-32.
5. Harper PS. Naming of syndromes and unethical activities: the case of Hallervorden and Spatz. Lancet 1996; 348(9036): 1224-1225.
6. Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching HK, Gitschier J. Genetic, Clinical, and Radiographic delineation of Hallervorden Spatz Syndrome. N Engl J Med 2003; 348(1): 33-40.
7. Thomas M, Hayflick SJ, Jancovic J. Clinical Heterogeneity of Neurodegeneration with Brain Iron Accumulation (Hallervorden Spatz Syndrome) and pantothenate Kinase associated neurodegeneration. Mov Disord 2004; 19 (1): 36-42.
8. Rock CO, Calder RB, Karim MA, Jackowski S. Pantothenate Kinase regulation of intracellular concentration of Coenzyme A. J Biol Chem 2000; 275: 1377-1383.
9. Hortnagel K, Prokisch H, Meitinger T. An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. Hum Mol Genet 2003; 12(3): 321-327.